Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test

Proposed LCD will allow Medicare coverage within criteria for the 4Kscore® Test MIAMI, June 28, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued a new proposed local coverage determination (LCD) for the 4Kscore® test, with defined coverage criteria.  Under the LCD, Medicare will reimburse the test for patients […]


Join the ZERO Cancer Movement

Support Awareness, Research & Advocacy At 4Kscore, our team is investing in the health and well-being of men facing a prostate cancer diagnosis. As part of our fall event schedule, we’re joining OPKO Health and thousands of prostate cancer patients, survivors, families and physicians participating in the ZERO Prostate Cancer Run/Walk movement.   About the […]


2018 AUA Exhibition:

OPKO Health Focuses Attention on 4Kscore Test Urologists from across the U.S. and over 100 countries around the globe gathered last month in San Francisco for the 113th American Urological Association (AUA) Conference. With this year’s event attendance topping 16,000, the annual event remains the largest urology meeting in the world. OPKO Health, developers of […]


Prostate Cancer Awareness: The Latest Numbers

Prostate cancer is the second-most common cancer in U.S. men and the second leading cause of cancer death for them. Thankfully, prostate cancer has a very good prognosis if detected early—before it has had a chance to spread. Why guess about your prostate health? If you’ve had an abnormal PSA, 4Kscore provides an accurate, personalized […]


Links Between Prostate Cancer & Osteoporosis:

Are You at Risk for Brittle Bones? May was Osteoporosis Awareness Month, and it shined a light on brittle-bone risk factors in women and men. Osteoporosis is a condition that weakens bones and often contributes to declining health in those over age 65. While the disease is most often associated with the loss of estrogen […]


New Clinical Study Reports: the 4Kscore Test Can Identify Men at Low Risk of Dying From Prostate Cancer Up to 20 Years After the Test Result

Reference: “Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men” Authors: Daniel D Sjoberg, Andrew J Vickers, Melissa Assel, Anders Dahlin, Bing Ying Poon, David Ulmert, Hans Lilja. 2018. Eur Urol A landmark study recently reported in European Urology […]